Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1296550
Corrigendum: Commentary: An evaluation of traditional Persian medicine for the management of SARS-CoV-2
- 1Department of Traditional Medicine, Institute for Studies in Medical History, Persian and Complementary Medicine, Iran University of Medical Sciences, Tehran, Iran
- 2Department of Traditional Medicine, School of Persian Medicine, Iran University of Medical Sciences, Tehran, Iran
- 3Student Research Committee Iran University of Medical Sciences, Tehran, Iran
- 4Traditional Medicine Clinical Trial Research Center, Shahed University, Tehran, Iran
by Mirhosseini H, Aliasl J and Eghbalian F (2023). Front. Pharmacol. 14:1124157. doi: 10.3389/fphar.2023.1124157
In the published article, there was an error in the author list, and author Fatemeh Eghbalian was erroneously excluded. The corrected author list appears below.
“Haniye Mirhosseini1,2,3, Jale Aliasl4 and Fatemeh Eghbalian1,2,*”
The Author Contributions were updated to include the contributions of the author, Fatemeh Eghbalian. The correct Author Contributions appear below.
“HM and FE searched the literature. HM, FE, and JA conceived and wrote the manuscript. All authors contributed to drafting the manuscript and approved the submitted version.”
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: SARS-CoV-2, traditional Persian medicine, cardio tonic, infection, herbal medicine
Citation: Mirhosseini H, Aliasl J and Eghbalian F (2023) Corrigendum: Commentary: An evaluation of traditional Persian medicine for the management of SARS-CoV-2. Front. Pharmacol. 14:1296550. doi: 10.3389/fphar.2023.1296550
Received: 19 September 2023; Accepted: 19 September 2023;
Published: 28 September 2023.
Approved by:Frontiers Editorial Office, Frontiers Media SA, Switzerland
Copyright © 2023 Mirhosseini, Aliasl and Eghbalian. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Fatemeh Eghbalian, email@example.com